Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins

Abstract Pneumolysin (PLY) is a cholesterol-dependent cytolysin (CDC) from Streptococcus pneumoniae, the main cause for bacterial pneumonia. Liberation of PLY during infection leads to compromised immune system and cytolytic cell death. Here, we report discovery, development, and validation of targe...

詳細記述

書誌詳細

出版年:	Nature Communications
主要な著者:	Umer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, Maren Mieth, Amira Atef, Thomas Rudolf, Christoph Arkona, Timo Trenkner, Christoph Böttcher, Kai Ludwig, Angelique Hoelzemer, Andreas C. Hocke, Gerhard Wolber, Jörg Rademann
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2024-04-01
オンライン･アクセス:	https://doi.org/10.1038/s41467-024-47741-3